Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas

Activating mutations within the epidermal growth factor (EGFR) tyrosine kinase domain identify non-small cell lung cancer patients with improved clinical response to tyrosine kinase inhibitor therapy. Recently, we identified two EGFR mutations in a cohort of 25 salivary gland carcinomas (SGCs) by sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahse, R, Driemel, O, Schwarz, S, Dahse, J, Kromeyer-Hauschild, K, Berndt, A, Kosmehl, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653741/
https://www.ncbi.nlm.nih.gov/pubmed/19174819
http://dx.doi.org/10.1038/sj.bjc.6604875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653741/
https://www.ncbi.nlm.nih.gov/pubmed/19174819
http://dx.doi.org/10.1038/sj.bjc.6604875

Ejemplares similares